HLA alleles as biomarkers of high-titre neutralising antibodies to interferon-β therapy in multiple sclerosis-Reference-Cited by-同舟云学术

HLA alleles as biomarkers of high-titre neutralising antibodies to interferon-β therapy in multiple sclerosis

Published:2014-04-19 Issue:6 Volume:51 Page:395-400
ISSN:0022-2593
Container-title:Journal of Medical Genetics
language:en
Short-container-title:J Med Genet

Author:

Núñez Concepción,Cénit Mª Carmen,Alvarez-Lafuente Roberto,Río Jordi,Fernández-Arquero Miguel,Arroyo Rafael,Montalbán Xavier,Fernández Oscar,Oliver-Martos Begoña,Leyva Laura,Comabella Manuel,Urcelay Elena

Publisher

BMJ

Subject

Genetics (clinical),Genetics

Reference38 articles.

1. Multiple sclerosis—the plaque and its pathogenesis;Frohman;N Engl J Med,2006

2. Risk alleles for multiple sclerosis identified by a genomewide study;Hafler;N Engl J Med,2007

3. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis;Sawcer;Nature,2011

4. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis;Beecham;Nat Genet,2013

5. Defining the response to interferon-beta in relapsing-remitting multiple sclerosis patients;Río;Ann Neurol,2006

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment- and population-specific genetic risk factors for anti-drug antibodies against interferon-beta: a GWAS;BMC Medicine;2020-11-04

2. Pharmacogenomics of drugs used to treat brain disorders;Expert Review of Precision Medicine and Drug Development;2020-03-17

3. Correlation between antidrug antibodies, pre-existing antidrug reactivity, and immunogenetics (MHC class II alleles) in cynomolgus macaque;Immunogenetics;2019-11

4. Pharmacogenomics of Multiple Sclerosis: A Systematic Review;Frontiers in Neurology;2019-02-26

5. Effect of HLA-DRB1 alleles and genetic variants on the development of neutralizing antibodies to interferon beta in the BEYOND and BENEFIT trials;Multiple Sclerosis Journal;2018-03-09